Phase two clinical trial of limited stage lymphoblastic lymphoma.
Phase 2
- Conditions
- imited stage lymphoblastic lymphoma
- Registration Number
- JPRN-jRCTs041180131
- Lead Sponsor
- Sekimizu Masahiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Newly diagnosed patients with limited T and B cell lymphoblastic lymphoma
Exclusion Criteria
1, Down's syndrome
2, previous malignancy of any type
3, Prior stem cell or organ transplantation
4, Congenital or acquired immunodeficiency
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3 year event-free survival
- Secondary Outcome Measures
Name Time Method (1) 3year overall survival<br>(2)Incidence of therapy-rerated severe toxicity